Wetzel EA, Nohman AI, Hsieh AL, Reuss D, et al. A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design. J Neurooncol 2024 Oct 21. doi: 10.1007/s11060-024-04852.
PMID: 39432026